[Parkinson disease: diagnostic and therapeutic criteria].
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D015259:Dopamine Agents / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D005917:Globus Pallidus / Q000601:surgery; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D020961:Lewy Body Disease / Q000175:diagnosis; D008090:Lisuride / Q000627:therapeutic use; D008297:Male; D008609:Mental Status Schedule; D009493:Neurosurgery; D010300:Parkinson Disease / Q000175:diagnosis* / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy*; D020734:Parkinsonian Disorders / Q000175:diagnosis* / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy; D010891:Piribedil / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013238:Stereotaxic Techniques; D013494:Supranuclear Palsy, Progressive / Q000175:diagnosis; D011795:Surveys and Questionnaires; D013788:Thalamus / Q000601:surgery
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D018491:Dopamine Agonists; D007211:Indoles; D017366:Serotonin Receptor Agonists; C046649:ropinirole; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine; D010891:Piribedil; D008090:Lisuride